RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

Exclusion Criteria

• •Patients receiving any other glucose lowering therapy which is not metformin or a sulfonylurea.
• •Patients with systolic blood pressure \>180 mmHg or diastolic blood pressure \>105 mmHg.
• •Patients who have required the use of insulin for glycaemic control at any time in the past.
• •Hospitalisation for any major cardiovascular event in the last 3 months.